GLP-1 weight-loss drugs may be followed by returning appetite and some weight regain

Some people who lost weight on GLP‑1 medications report returning hunger and modest weight regain even while continuing treatment; doctors say biological signals that defend a higher body weight can reassert themselves months to years after initial loss.

A number of people who initially lost significant weight on GLP‑1 medications later experienced renewed hunger and some weight regain while continuing the drug. The article describes a patient who lost about 60 pounds on weekly injections and then regained roughly 10 pounds despite ongoing treatment. GLP‑1 drugs mimic gut hormones and blunt appetite, but clinicians say the body's biological systems that defend a prior, higher weight can intensify over time. Physicians report that rapid weight loss often occurs in the first months, then typically plateaus within about nine to 18 months. What is known: - Some patients report returning appetite, food-related thoughts, and gradual weight regain while still taking GLP‑1 medications such as semaglutide and tirzepatide. - Doctors describe a pattern of fastest weight loss in the first four to six months and a plateau around nine to 18 months; they attribute later regain to the body’s compensatory mechanisms rather than simple medication failure. - Manufacturers have reported trial plateaus near 60 weeks, and one company filed for approval of a higher-dose formulation; clinicians say options include dose adjustments or switching medications in some cases. Summary: People who initially respond to GLP‑1 treatment can experience a return of hunger and partial weight regain over time while remaining on medication. Some clinicians adjust dosing or try alternative drugs, and a maker has sought approval for a higher dose formulation. Undetermined at this time.